Barbara M McGowan (Barbara McGowan)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Cardiovascular Risk Factors

Health Insurance

Placebo Controlled

Top Venues

Obesity (Silver Spring, Md.)

Clinical obesity

International journal of obesity (2005)

This page only lists publications with an associated author ORCID identifier.

Publications

Laurence J Dobbie, Claudia Coelho, Farah Mgaieth, Keisha Chauhan, Scott Campbell, Sumaya Shuriye, Joanna Hollington, Sarah Appleton, Piya Sen Gupta, Alastair Duncan, Barbara M McGowan
Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real-world UK data: A clinical evaluation of a multi-ethnic population. Clinical obesity 14 (3) (2024)
Laurence J Dobbie, Claudia Coelho, Farah Mgaieth, Keisha Chauhan, Scott Campbell, Sumaya Shuriye, Joanna Hollington, Sarah Appleton, Piya Sen Gupta, Alastair Duncan, Barbara M McGowan
Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real-world UK data: A clinical evaluation of a multi-ethnic population. Clinical obesity (2024)
Barbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen, Niels Zeuthen, James Baker-Knight
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial. Obesity (Silver Spring, Md.) (2023)
Barbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen, Niels Zeuthen, James Baker-Knight
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial. Obesity (Silver Spring, Md.) 31 (4) (2023)
Robert F Kushner, Anders Fink-Jensen, Ofir Frenkel, Barbara M McGowan, Bryan Goldman, Maria Overvad, Thomas A Wadden
Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis. Obesity (Silver Spring, Md.) (2023)
Barbara M McGowan, Azadeh Houshmand-Oeregaard, Peter Nørkjaer Laursen, Niels Zeuthen, James Baker-Knight
Impact of BMI and comorbidities on efficacy of once-weekly semaglutide: Post hoc analyses of the STEP 1 randomized trial. Obesity (Silver Spring, Md.) 31 (4) (2023)
Claudia Coelho, Laurence J Dobbie, James Crane, Abdel Douiri, Annastazia E Learoyd, Olanike Okolo, Spyros Panagiotopoulos, Dimitri J Pournaras, Sasindran Ramar, Francesco Rubino, Rishi Singhal, Carel W le Roux, Shahrad Taheri, Barbara M McGowan
Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE): a pilot randomised placebo controlled trial. International journal of obesity (2005) (2023)